ES8506663A1 - Un procedimiento para la preparacion de derivados de ariltiazolidindiona - Google Patents

Un procedimiento para la preparacion de derivados de ariltiazolidindiona

Info

Publication number
ES8506663A1
ES8506663A1 ES528887A ES528887A ES8506663A1 ES 8506663 A1 ES8506663 A1 ES 8506663A1 ES 528887 A ES528887 A ES 528887A ES 528887 A ES528887 A ES 528887A ES 8506663 A1 ES8506663 A1 ES 8506663A1
Authority
ES
Spain
Prior art keywords
alkoxyphenyl
thiazolidinediones
aldose reductase
reductase inhibiting
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES528887A
Other languages
English (en)
Other versions
ES528887A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8506663A1 publication Critical patent/ES8506663A1/es
Publication of ES528887A0 publication Critical patent/ES528887A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Paints Or Removers (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE ARILTIAZOLIDINDIONA, DE FORMULA GENERAL (I), EN LA QUE R ES ALQUILO DE A 1 A 4 ATOMOS DE CARBONO; X ES FLUOR, CLORO O BROMO; E Y ES HIDROGENO, CLORO, ALQUILO INFERIOR O ALCOXI INFERIOR, Y SUS SALES BASICA CON CATIONES FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN HACER REACCIONAR UN ESTER ALQUILICO DE UN ACIDO BAB-(2-ALCOXIFENIL)-BAB-CLOROACETICO, DE FORMULA GENERAL (II), EN LA QUE R1 ES ALQUILO C1C4 CON TIOUREA, EN UN DISOLVENTE INERTE A LA REACCION Y A UNA TEMPERATURA DE 75 GRADOS COMO MINIMO, Y EN HIDROLIZAR LA 5-(2-ALCOXIFENIL)-2-IMINOTIAZOLIDIN-4-ONA, ASI PRODUCIDA, CON UNA SOLUCION ACUOSA DILUIDA.DE APLICACION EN EL TRATAMIENTO DE LA DIABETES CRONICA.
ES528887A 1983-01-17 1984-01-16 Un procedimiento para la preparacion de derivados de ariltiazolidindiona Granted ES528887A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45868483A 1983-01-17 1983-01-17

Publications (2)

Publication Number Publication Date
ES8506663A1 true ES8506663A1 (es) 1985-08-01
ES528887A0 ES528887A0 (es) 1985-08-01

Family

ID=23821708

Family Applications (1)

Application Number Title Priority Date Filing Date
ES528887A Granted ES528887A0 (es) 1983-01-17 1984-01-16 Un procedimiento para la preparacion de derivados de ariltiazolidindiona

Country Status (26)

Country Link
EP (1) EP0117035B1 (es)
JP (1) JPS59137474A (es)
KR (1) KR870001267B1 (es)
AT (1) ATE45574T1 (es)
AU (1) AU539921B2 (es)
CA (1) CA1233470A (es)
CS (1) CS241149B2 (es)
DD (1) DD216012A5 (es)
DE (1) DE3479419D1 (es)
DK (1) DK17984A (es)
EG (1) EG16563A (es)
ES (1) ES528887A0 (es)
FI (1) FI840155A (es)
GR (1) GR79763B (es)
GT (1) GT198400006A (es)
HU (1) HU191265B (es)
IE (1) IE56842B1 (es)
IL (1) IL70690A (es)
NO (1) NO162462C (es)
NZ (1) NZ206845A (es)
PH (1) PH18882A (es)
PL (1) PL142152B1 (es)
PT (1) PT77958B (es)
SU (1) SU1189341A3 (es)
YU (1) YU43336B (es)
ZA (1) ZA84305B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210339B (en) 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
GB8910639D0 (en) * 1989-05-09 1989-06-21 Beecham Group Plc Novel compounds
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
JP3053490B2 (ja) * 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
EP4273132A3 (en) * 2017-03-03 2024-01-10 Gilead Sciences, Inc. Processes for preparing acc inhibitors and solid forms thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2263296A1 (de) * 1972-12-23 1974-06-27 Bayer Ag 4-alkyl-thiazol-2-one, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPS56104876A (en) * 1980-01-24 1981-08-20 Takeda Chem Ind Ltd Thiazolidine derivative
JPS5728075A (en) * 1980-07-29 1982-02-15 Takeda Chem Ind Ltd Thiazolidine derivative
JPS5728073A (en) * 1980-07-29 1982-02-15 Takeda Chem Ind Ltd Inhibitor for aldose reducing enzyme
JPS57123175A (en) * 1981-01-26 1982-07-31 Takeda Chem Ind Ltd Preparation of thiazolidine derivative

Also Published As

Publication number Publication date
IE56842B1 (en) 1992-01-01
PT77958A (en) 1984-02-01
GT198400006A (es) 1985-07-06
FI840155A (fi) 1984-07-18
KR870001267B1 (ko) 1987-06-30
AU539921B2 (en) 1984-10-25
EP0117035A3 (en) 1987-01-14
GR79763B (es) 1984-10-31
CA1233470A (en) 1988-03-01
ATE45574T1 (de) 1989-09-15
SU1189341A3 (ru) 1985-10-30
EG16563A (en) 1989-06-30
CS241149B2 (en) 1986-03-13
AU2328784A (en) 1984-07-19
ES528887A0 (es) 1985-08-01
IE840079L (en) 1984-07-17
PL142152B1 (en) 1987-09-30
EP0117035A2 (en) 1984-08-29
YU6184A (en) 1986-06-30
KR840007223A (ko) 1984-12-06
JPS59137474A (ja) 1984-08-07
JPH0329073B2 (es) 1991-04-23
NO162462B (no) 1989-09-25
DK17984D0 (da) 1984-01-16
DK17984A (da) 1984-07-18
DD216012A5 (de) 1984-11-28
NO162462C (no) 1990-01-03
CS38584A2 (en) 1985-07-16
IL70690A0 (en) 1984-04-30
PT77958B (en) 1986-06-18
EP0117035B1 (en) 1989-08-16
HU191265B (en) 1987-01-28
PL245745A1 (en) 1984-10-22
YU43336B (en) 1989-06-30
NO840144L (no) 1984-07-18
PH18882A (en) 1985-10-22
DE3479419D1 (en) 1989-09-21
FI840155A0 (fi) 1984-01-16
NZ206845A (en) 1986-09-10
ZA84305B (en) 1985-08-28
IL70690A (en) 1989-01-31

Similar Documents

Publication Publication Date Title
IE791592L (en) Spiro-oxazole derivatives
EP0201742A3 (en) N-acylpyrrolidine derivatives, processes for preparing them, pharmaceutical composition and use
AU575668B2 (en) N - acylpyrrolidine compound
IE800571L (en) Spiro-imidazolidine.
IE802661L (en) Isoquinoline acetic acids
IE791540L (en) Spiro-furanohydantoin derivatives
ES8506663A1 (es) Un procedimiento para la preparacion de derivados de ariltiazolidindiona
AU5801286A (en) Spiro-imidazolidines as aldose reductase inhibitors
ATE34661T1 (de) Verbindungen zur verminderung des lipidspiegels.
CA2030346A1 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
ES8504144A1 (es) Un procedimiento para la preparacion de una 5-(2-alcoxi-fenil 3-sustituido)hidantoina
IE832854L (en) Spiro-3-hetero-azolones for treatment of diabetic¹complications.
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
IE800109L (en) Spiro-quinolylhydantoins
ES8507119A1 (es) Procedimiento para la preparacion de un compuesto de 5-(fenil sustituido) hidantoina.
DE3467166D1 (en) Spiro-succinimides for treatment of diabetes complications

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203